Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christine E. Sheffer is active.

Publication


Featured researches published by Christine E. Sheffer.


American Journal on Addictions | 2012

Delay Discounting, Locus of Control, and Cognitive Impulsiveness Independently Predict Tobacco Dependence Treatment Outcomes in a Highly Dependent, Lower Socioeconomic Group of Smokers

Christine E. Sheffer; James MacKillop; John E. McGeary; Reid D. Landes; Lawrence P. Carter; Richard Yi; Bryan A. Jones; Darren R Christensen; Maxine Stitzer; Lisa Jackson; Warren K. Bickel

Tobacco use disproportionately affects lower socioeconomic status (SES) groups. Current explanations as to why lower SES groups respond less robustly to tobacco control efforts and tobacco dependence treatment do not fully account for this disparity. The identification of factors that predict relapse in this population might help to clarify these differences. Good candidates for novel prognostic factors include the constellation of behaviors associated with executive function including self-control/impulsiveness, the propensity to delay reward, and consideration and planning of future events. This study examined the ability of several measures of executive function and other key clinical, psychological, and cognitive factors to predict abstinence for highly dependent lower SES participants enrolled in intensive cognitive-behavioral treatment for tobacco dependence. Consistent with predictions, increased discounting and impulsiveness, an external locus of control as well as greater levels of nicotine dependence, stress, and smoking for negative affect reduction predicted relapse. These findings suggest that these novel factors are clinically relevant in predicting treatment outcomes and suggest new targets for therapeutic assessment and treatment approaches.


Journal of Evaluation in Clinical Practice | 2009

Training health care providers in the treatment of tobacco use and dependence: pre- and post-training results

Christine E. Sheffer; Claudia P. Barone; Michael Anders

RATIONALE Health care providers have an extended reach into the population of tobacco users. Increasing the number and variety of health care providers that deliver the evidence-based, brief interventions for tobacco use prescribed by the Public Health Service Clinical Practice Guideline is likely to result in more tobacco users exposed to evidence-based treatments and more successful quit attempts. Effective training is key to increasing provider performance and proficiency in this regard. METHOD A 1-hour didactic training was delivered to 1286 health care providers (185 physicians, 359 nurses, 75 dental providers and 667 other health-related professions). Pre- and post-training tests assessed provider attitudes, knowledge and behaviours. Paired samples t-tests were used to compare pre- and post-test results. Analysis of variance was used to test for significant differences among professional groups. RESULTS Prior to training, physicians engaged in more interventions and reported more knowledge and more positive attitudes towards treating tobacco use than the other professions. Post-training, differences among physicians, nurses and dental providers were minimal. All professions reported significantly more knowledge and more positive attitudes on nearly all measures. CONCLUSIONS A large potential benefit can be garnered from a brief, targeted, 1-hour training in the brief, evidence-based interventions for treating tobacco use and dependence. Increases in perceived knowledge and positive attitudes towards treatment among the professional groups suggest that trainees will perform interventions at higher frequency post-training. Overall gains were highest for dental providers and nurses.


Addictive Behaviors | 2014

Delay discounting rates: A strong prognostic indicator of smoking relapse

Christine E. Sheffer; Darren R. Christensen; Reid D. Landes; Larry P. Carter; Lisa Jackson; Warren K. Bickel

BACKGROUND Recent evidence suggests that several dimensions of impulsivity and locus of control are likely to be significant prognostic indicators of relapse. METHOD One-hundred and thirty-one treatment seeking smokers were enrolled in six weeks of multi-component cognitive-behavioral therapy with eight weeks of nicotine replacement therapy. ANALYSIS Cox proportional hazard regressions were used to model days to relapse with each of the following: delay discounting of


American Journal of Public Health | 2012

Socioeconomic Disparities in Community-Based Treatment of Tobacco Dependence

Christine E. Sheffer; Maxine L. Stitzer; Reid D. Landes; S. Laney Brackman; Tiffany Munn; Page C. Moore

100, delay discounting of


Journal of Evaluation in Clinical Practice | 2008

A survey of tobacco-related knowledge, attitudes and behaviours of primary care providers in Mississippi

Bradford W. Applegate; Christine E. Sheffer; Karen M. Crews; Thomas J. Payne; Patrick O. Smith

1000, six subscales of the Barratt Impulsiveness Scale (BIS), Rotters Locus of Control (RLOC), Fagerstroms Test for Nicotine Dependence (FTND), and the Perceived Stress Scale (PSS). Hazard ratios for a one standard deviation increase were estimated with 95% confidence intervals for each explanatory variable. Likelihood ratios were used to examine the level of association with days to relapse for different combinations of the explanatory variables while accounting for nicotine dependence and stress level. RESULTS These analyses found that the


Journal of Substance Abuse Treatment | 2013

Neuromodulation of delay discounting, the reflection effect, and cigarette consumption

Christine E. Sheffer; Mark Mennemeier; Reid D. Landes; Warren K. Bickel; Sharon Brackman; John L. Dornhoffer; Timothy Kimbrell; Ginger Brown

100 delay discounting rate had the strongest association with days to relapse. Further, when discounting rates were combined with the FTND and PSS, the associations remained significant. When the other measures were combined with the FTND and PSS, their associations with relapse non-significant. CONCLUSIONS These findings indicate that delay discounting is independently associated with relapse and adds to what is already accounted for by nicotine dependence and stress level. They also signify that delay discounting is a productive new target for enhancing treatment for tobacco dependence. Consequently, adding an intervention designed to decrease discounting rates to a comprehensive treatment for tobacco dependence has the potential to decrease relapse rates.


Preventive Medicine | 2016

Sex/gender differences in smoking cessation: A review

Philip H. Smith; Andrew Bessette; Andrea H. Weinberger; Christine E. Sheffer; Sherry A. McKee

OBJECTIVES We examined socioeconomic disparities in a community-based tobacco dependence treatment program. METHODS We provided cognitive-behavioral treatment and nicotine patches to 2739 smokers. We examined treatment use, clinical and environmental, and treatment outcome differences by socioeconomic status (SES). We used logistic regressions to model end-of-treatment and 3- and 6-month treatment outcomes. RESULTS The probability of abstinence 3 months after treatment was 55% greater for the highest-SES than for the lowest-SES (adjusted odds ratio [AOR] = 1.55; 95% confidence interval [CI] = 1.03, 2.33) smokers and increased to 2.5 times greater for the highest-SES than for the lowest-SES smokers 6 months after treatment (AOR = 2.47; 95% CI = 1.62, 3.77). Lower-SES participants received less treatment content and had fewer resources and environmental supports to manage a greater number of clinical and environmental challenges to abstinence. CONCLUSIONS Targets for enhancing therapeutic approaches for lower socioeconomic groups should include efforts to ensure that lower-SES groups receive more treatment content, strategies to address specific clinical and environmental challenges associated with treatment outcomes for lower-SES smokers (i.e., higher dependence and stress levels and exposure to other smokers), and strategies to provide longer-term support.


Preventive Medicine | 2014

A Competing Neurobehavioral Decision Systems model of SES-related health and behavioral disparities

Warren K. Bickel; Lara Moody; Amanda J. Quisenberry; Craig T. Ramey; Christine E. Sheffer

RATIONALE Relative to other regions in the USA, Mississippi has a high prevalence of tobacco use and tobacco-related disease. This study assessed the tobacco-related knowledge, attitudes and intervention behaviours of family doctors, dentists and nurse practitioners in the state of Mississippi. METHODS The Provider Attitude Survey, an 85-item measure of tobacco-related knowledge, attitudes and intervention behaviours was mailed to all members of Mississippis Family Medicine, Dentistry and Nurse Practitioner professional organizations (N=2043). RESULTS Over one-third (n=802, 39.2%) of eligible providers responded. Just 24.3% had received training in tobacco cessation and 33.7% were aware of the Public Health Service clinical practice guideline. Over 90% indicated that it was their role to prevent tobacco use; felt rewarded when they helped patients quit; and were bothered and upset by the health effects of tobacco. Doctors assisted more patients than nurses or dentists. Doctors and nurses reported more self-efficacy, motivation and preparedness for treating tobacco use than dentists. Providers with training performed more interventions and reported more self-efficacy, preparedness and fewer barriers than those without training. Training was associated with greater increases in self-efficacy, preparedness and intervention behaviours for dentists than for the other groups. CONCLUSIONS Despite a high prevalence of tobacco use and tobacco-related disease in Mississippi, primary care providers in Mississippi provide tobacco cessation interventions at an unacceptably low frequency relative to other regions. Training is likely to increase the frequency of intervention behaviours.


Journal of Advanced Nursing | 2011

Training Nurses in the Treatment of Tobacco Use and Dependence: Pre- and Post-Training Results

Christine E. Sheffer; Claudia P. Barone; Michael Anders

Cigarette smokers and substance users discount the value of delayed outcomes more steeply than non-users. Higher discounting rates are associated with relapse and poorer treatment outcomes. The left dorsolateral prefontal cortex (DLPFC) exerts an inhibitory influence on impulsive or seductive choices. Greater activity in the prefrontal cortex is associated with lower discounting rates. We hypothesized that increasing activity in the left DLPFC with high frequency repetitive transcranial magnetic stimulation (HF rTMS) would decrease delay discounting and decrease impulsive decision-making in a gambling task as well as decrease cigarette consumption, similar to other studies. In this single-blind, within-subjects design, smokers with no intention to quit (n = 47) and nonsmokers (n = 19) underwent three counterbalanced sessions of HF rTMS (20 Hz, 10 Hz, sham) delivered over the left DLPFC. Tasks were administered at baseline and after each stimulation session. Stimulation decreased discounting of monetary gains (F([3,250]) = 4.46, p < .01), but increased discounting of monetary losses (F([3,246]) = 4.30, p < .01), producing a reflection effect, normally absent in delay discounting. Stimulation had no effect on cigarette consumption. These findings provide new insights into cognitive processes involved with decision-making and cigarette consumption and suggest that like all medications for substance dependence, HF rTMS is likely to be most effective when paired with cognitive-behavioral interventions.


American Journal of Health Promotion | 2009

Treatment for Tobacco Dependence for Rural, Lower-Income Smokers: Outcomes, Predictors, and Measurement Considerations

Christine E. Sheffer; Maxine L. Stitzer; Thomas J. Payne; Bradford W. Applegate; David Bourne; J. Gary Wheeler

Data from treatment studies tends to show women are less likely to quit smoking than men, but these findings have been disputed, typically based on contradictory evidence from epidemiological investigations. The purpose of this review was to shed light on this conflict. We conducted a qualitative review in January 2016 to examine sources of variation in sex/gender differences for smoking cessation. We identified 214 sex/gender difference tests from 190 studies through Medline and studies were categorized into efficacy trials (k=37), effectiveness trials (k=77), prospective observational studies of cessation (k=40; current smokers transitioning to former smokers), prospective observational studies of relapse (k=6; former smokers transitioning to current smokers), cross-sectional investigations of former smoker prevalence (k=32), and community-based interventions (k=4). We also summarized evidence across time periods, countries, outcome assessments, study sample, and treatment. Evidence from efficacy and effectiveness trials, as well as prospective observational studies of relapse, demonstrated that women have more difficulty maintaining long-term abstinence than men. Findings from prospective observational studies and cross-sectional investigations were mixed and demonstrated that bio-psycho-social variation in samples across place and time may determine whether or not women or men are less likely to quit smoking. Based on these findings, we consider whether sex/gender differences in quitting meet criteria for a disparity and outline directions for further research.

Collaboration


Dive into the Christine E. Sheffer's collaboration.

Top Co-Authors

Avatar

Reid D. Landes

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

S. Laney Brackman

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Thomas J. Payne

University of Mississippi Medical Center

View shared research outputs
Top Co-Authors

Avatar

Tiffany Munn

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Maxine L. Stitzer

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Maxine Stitzer

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Sharon Brackman

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Claudia P. Barone

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge